167 related articles for article (PubMed ID: 31261447)
1. Predictors of long-term abstinence rate by income level in the Korean smoking cessation programme.
Seo YG; Paek YJ; Jo MW; Choi J
Addiction; 2019 Nov; 114(11):2056-2064. PubMed ID: 31261447
[TBL] [Abstract][Full Text] [Related]
2. Moderators of real-world effectiveness of smoking cessation aids: a population study.
Jackson SE; Kotz D; West R; Brown J
Addiction; 2019 Sep; 114(9):1627-1638. PubMed ID: 31117151
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES.
West R; Evins AE; Benowitz NL; Russ C; McRae T; Lawrence D; St Aubin L; Krishen A; Maravic MC; Anthenelli RM
Addiction; 2018 Aug; 113(8):1507-1516. PubMed ID: 29508470
[TBL] [Abstract][Full Text] [Related]
4. Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential.
Versace F; Stevens EM; Robinson JD; Cui Y; Deweese MM; Engelmann JM; Green CE; Karam-Hage M; Lam CY; Minnix JA; Wetter DW; Cinciripini PM
Nicotine Tob Res; 2019 Jan; 21(2):234-240. PubMed ID: 29220524
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
Zhong Z; Zhao S; Zhao Y; Xia S
Compr Psychiatry; 2019 Nov; 95():152125. PubMed ID: 31669972
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan.
Chang PY; Shiu MN; Yuan YT; Chang HC; Su PY; Lan TH
Nicotine Tob Res; 2019 Jan; 21(2):149-155. PubMed ID: 29294121
[TBL] [Abstract][Full Text] [Related]
7. [Smoking cessation: Pharmacological strategies different from standard treatments].
Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of varenicline and counselling for smoking cessation in an observational cohort study in China.
Jiang B; He Y; Zuo F; Wu L; Liu QH; Zhang L; Zhou CX; Cheng KK; Chan SS; Lam TH
BMJ Open; 2016 Jan; 6(1):e009381. PubMed ID: 26739730
[TBL] [Abstract][Full Text] [Related]
9. Predictors of success for smoking cessation at the workplace: a longitudinal study.
Stolz D; Scherr A; Seiffert B; Kuster M; Meyer A; Fagerström KO; Tamm M
Respiration; 2014; 87(1):18-25. PubMed ID: 23594795
[TBL] [Abstract][Full Text] [Related]
10. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials.
Nagano T; Katsurada M; Yasuda Y; Kobayashi K; Nishimura Y
Ther Adv Respir Dis; 2019; 13():1753466619875925. PubMed ID: 31533544
[TBL] [Abstract][Full Text] [Related]
11. Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial.
Politis A; Ioannidis V; Gourgoulianis KI; Daniil Z; Hatzoglou C
Chron Respir Dis; 2018 May; 15(2):146-156. PubMed ID: 29117796
[TBL] [Abstract][Full Text] [Related]
12. Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time.
Stepankova L; Kralikova E; Zvolska K; Pankova A; Adamcekova Z; Kuhn M; Noland D
Addiction; 2021 Feb; 116(2):346-355. PubMed ID: 32592219
[TBL] [Abstract][Full Text] [Related]
13. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
14. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
15. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
16. If at first you don't succeed: characterization of smokers with late smoking abstinence onset.
Leyro TM; Hendricks PS; Hall SM
Addict Behav; 2015 Jun; 45():34-8. PubMed ID: 25637886
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of bupropion and counseling for smoking cessation].
Jiang B; He Y; Zuo F; Wu L; Liu QH; Zhang L; Zhou CX; Cheng JJ; Chan Sc ZS; Lam DQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jul; 50(7):640-4. PubMed ID: 27412843
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan.
Chang PY; Lo PC; Chang HC; Hsueh KC; Tsai YW
PLoS One; 2016; 11(11):e0166992. PubMed ID: 27893843
[TBL] [Abstract][Full Text] [Related]
19. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
Panagiotou OA; Schuit E; Munafò MR; Bennett DA; Bergen AW; David SP
Nicotine Tob Res; 2019 Aug; 21(9):1289-1293. PubMed ID: 30690475
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD.
Qin R; Liu Z; Cheng AQ; Zhou XM; Su Z; Cui ZY; Li JX; Wei XW; Zhao L; Chung KF; Xiao D; Wang C
Respirology; 2024 Jun; 29(6):479-488. PubMed ID: 38494828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
